Oncol Nurs Forum. 2026 Feb 25;53(2):e26535281. doi: 10.1188/26.ONF.e26535281.
ABSTRACT
OBJECTIVES: To assess racial and ethnic differences in prostate-specific antigen (PSA) screening and shared decision-making (SDM) and examine whether SDM modifies screening rates by race and ethnicity.
SAMPLE & SETTING: Data from the 2021-2023 Behavioral Risk Factor Surveillance System were analyzed, including 10,778 men aged 55-69 years eligible for PSA screening.
METHODS & VARIABLES: Descriptive statistics and chi-square tests assessed racial and ethnic differences in PSA screening and estimated SDM (eSDM) use. Multiple logistic regression models evaluated the impact of eSDM on PSA screening rates, including an interaction term for race and ethnicity and eSDM.
RESULTS: Among the sample, 46% reported undergoing PSA screening in the past year. eSDM was a significant predictor of PSA screening. After adjusting for eSDM and covariates, racial disparities in screening rates were no longer significant. Only Asian American men showed a significantly lower likelihood of screening following SDM exposure compared to White men.
IMPLICATION FOR NURSING: SDM can reduce racial and ethnic disparities in PSA screening. In addition, factors like healthcare access significantly influence screening rates, requiring targeted investigation. The results call for further investigation to culturally optimize SDM.
PMID:41812019 | DOI:10.1188/26.ONF.e26535281
